Mechanisms of action of the dipeptidyl peptidase‐4 inhibitor vildagliptin in humans
Year: 2011
Type: review
Source: Diabetes Obesity and Metabolism
Institutions: Lund University, Novartis (Switzerland), Novartis (France)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1805640194
